Serpi Michaela, De Biasi Roberto, Pertusati Fabrizio, Slusarczyk Magdalena, McGuigan Christopher
School of Pharmacy and Pharmaceutical Sciences Cardiff University King Edward VII Avenue Cardiff CF10 3NB UK).
Dipartimento di Scienze Farmaceutiche Università degli Studi di PerugiaVia del Liceo 1 06123 Perugia Italy.
ChemistryOpen. 2017 May 5;6(3):424-436. doi: 10.1002/open.201700019. eCollection 2017 Jun.
A synthetic procedure for the preparation of phosphoramidate prodrugs of -nucleosides is reported. Different phosphorochloridates were reacted with 3'--protected -acetyl-2'-deoxypseudoisocytidine or 3'--protected 2'-deoxypseudoisocytidine, followed by acidic hydrolysis of the protecting group. In the presence of the -acetyl moiety, the enolisable keto group of the nucleobase was able to react (like the 5'-OH) with the phosphorochloridates to give bisphosphorylated derivatives. Epimerisation (β to α) occurred if the amino group of the nucleobase was unprotected. These side reactions demonstrate the peculiar behaviour of -nucleosides compared to their nucleoside analogues. It was demonstrated that the first enzymatic activation step for this new class of prodrugs can be mediated by carboxypeptidase and that it follows the same pathway and rate reported for ProTides of more conventional nucleoside analogues. These new phosphoramidate derivatives deserve further investigation for their therapeutic potential as anti-cancer agents.
报道了一种合成β-核苷磷酰胺酯前药的方法。不同的磷酰氯与3'-O-保护的β-乙酰基-2'-脱氧假异胞苷或3'-O-保护的2'-脱氧假异胞苷反应,随后对保护基团进行酸水解。在存在β-乙酰基部分的情况下,核碱基的可烯醇化酮基能够(像5'-OH一样)与磷酰氯反应生成双磷酸化衍生物。如果核碱基的氨基未被保护,则会发生差向异构化(β到α)。这些副反应表明β-核苷与其核苷类似物相比具有独特的行为。结果表明,这类新前药的第一个酶促活化步骤可由羧肽酶介导,并且它遵循与更传统核苷类似物的ProTides报道的相同途径和速率。这些新的磷酰胺酯衍生物作为抗癌剂的治疗潜力值得进一步研究。